Trials / Terminated
TerminatedNCT02204332
Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment
Phase II-b Randomized Study of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Hospital Clinico Universitario de Santiago · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine efficacy and safety of cabazitaxel administration in patients with colorectal cancer resistant to standard treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cabazitaxel | |
| OTHER | Best Supportive Care |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-09-01
- First posted
- 2014-07-30
- Last updated
- 2014-07-30
Locations
8 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02204332. Inclusion in this directory is not an endorsement.